| 注册
首页|期刊导航|新医学|治疗前格拉斯哥评分及血液炎性指标与鼻咽癌患者预后相关性研究

治疗前格拉斯哥评分及血液炎性指标与鼻咽癌患者预后相关性研究

李晓惠 许啸 范元平 文娟 陈静茹 夏云飞

新医学2024,Vol.55Issue(5):328-334,7.
新医学2024,Vol.55Issue(5):328-334,7.DOI:10.3969/j.issn.0253-9802.2024.05.002

治疗前格拉斯哥评分及血液炎性指标与鼻咽癌患者预后相关性研究

Study on the correlation between pre-treatment Glasgow score and blood inflammatory markers and prognosis of nasopharyngeal carcinoma patients

李晓惠 1许啸 1范元平 1文娟 1陈静茹 1夏云飞2

作者信息

  • 1. 32265部队肿瘤科,广东 广州 510318
  • 2. 中山大学肿瘤防治中心放疗科,广东 广州 510060||中山大学肿瘤防治中心 华南肿瘤学国家重点实验室,广东 广州 510060
  • 折叠

摘要

Abstract

Objective To investigate the correlation between Glasgow score and blood inflammatory markers before treatment with the efficacy of nasopharyngeal carcinoma.Methods Cases from the two clinical centers were divided into training set and validation set,and the clinical characteristics of the two groups were compared to be balanced.To search the independent prognostic risk factors of nasopharyngeal carcinoma and then the prognostic index of each patient was calculated,and the patients were divided into high-risk,intermediate-risk and low-risk groups.Further validation in the validation set.Results Cox multivariate analysis of the training set showed that age>50,T3-T4,N2-N3,GPS score of 1-2,NLR>2.5,and LMR≤2.35 before treatment were poor prognostic factors affecting the 5-year disease-specific survival rate of patients with nasopharyngeal carcinoma.Conclusion The combination of GPS,NLR,LMR and age,TNM staging may provide a new way for the prognosis evaluation of patients with nasopharyngeal carcinoma before treatment.

关键词

鼻咽癌/中性粒细胞与淋巴细胞比值/格拉斯哥预后评分/血小板与淋巴细胞比值/淋巴细胞与单核细胞比值

Key words

Nasopharyngeal carcinoma/Glasgow prognostic score/Neutrophil lymphocyte ratio/Platelet lymphocyte ratio/Lymphocyte mononuclear ratio

引用本文复制引用

李晓惠,许啸,范元平,文娟,陈静茹,夏云飞..治疗前格拉斯哥评分及血液炎性指标与鼻咽癌患者预后相关性研究[J].新医学,2024,55(5):328-334,7.

基金项目

国家高技术研究发展计划(863计划)(2006AA0224B4) (863计划)

广东省医学科学技术研究基金项目(A2018552 ()

B2022288) ()

新医学

OACSTPCD

0253-9802

访问量0
|
下载量0
段落导航相关论文